Soluble CD46 as a diagnostic marker of hepatic steatosis

URN to cite this document:: urn:nbn:de:bvb:355-epub-584094
DOI to cite this document:: 10.5283/epub.58409

Bitterer, Florian

; Kupke, Paul

; Adenugba, Akinbami ; Evert, Katja

; Glehr, Gunther

; Riquelme, Paloma

; Scheibert, Lena ; Preverin, Giulia ; Böhm, Christina ; Hornung, Matthias

; Schlitt, Hans J.

; Wenzel, Jürgen J.

; Geissler, Edward K.

; Safinia, Niloufar ; Hutchinson, James A.

; Werner, Jens M.

License: Creative Commons Attribution 4.0
PDF - Published Version
(430kB)

Date of publication of this fulltext: 11 Jun 2024 05:58

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Background The increasing prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) incurs substantial morbidity, mortality and healthcare costs. Detection and clinical intervention at early stages of disease improves prognosis; however, we are currently limited by a lack of reliable diagnostic tests for population screening and monitoring responses to therapy. To address ...